Prognostic value of proliferating cell nuclear antigen (PCNA) expression in unresectable hepatocellular carcinoma

Marco Colleoni, Mariarosa Biasin, Luca Boni, Patrizia Nelli, Francesca Pancheri, Giovanni Vicario, Gigliola Sgarbossa, Giorgio Mastrapasqua, Domenico Infantolino, Paolo Manente

Research output: Contribution to journalArticle

Abstract

Recent studies indicate that evaluation of cell proliferation in malignant tumors may have prognostic value, but limited data are available on its expression in hepatocellular carcinoma. We therefore evaluated the prognostic tool of PCNA antigen expression on paraffin-embedded sections of 54 patients with hepatocellular carcinoma and concomitant cirrhosis. According to the number of positive cells, the PCNA expression ranged between 0.8 and 47%, and was divided into two groups (Group A, PCNA ≤5.5%; Group B, PCNA >5.5%). The two groups of patients were numerically well balanced. Median survival was 16 months for group A and 12 months for group B. According to the Cox multivariate analysis, PCNA expression (P=0.002), TNM stage (P-0.009) and ECOG performance status (P

Original languageEnglish
Pages (from-to)541-545
Number of pages5
JournalInternational Journal of Oncology
Volume9
Issue number3
Publication statusPublished - Sep 1996

Fingerprint

Proliferating Cell Nuclear Antigen
Hepatocellular Carcinoma
Paraffin
Fibrosis
Multivariate Analysis
Cell Count
Cell Proliferation
Antigens
Survival
Neoplasms

Keywords

  • hepatocellular carcinoma
  • PCNA expression
  • prognostic factors

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Prognostic value of proliferating cell nuclear antigen (PCNA) expression in unresectable hepatocellular carcinoma. / Colleoni, Marco; Biasin, Mariarosa; Boni, Luca; Nelli, Patrizia; Pancheri, Francesca; Vicario, Giovanni; Sgarbossa, Gigliola; Mastrapasqua, Giorgio; Infantolino, Domenico; Manente, Paolo.

In: International Journal of Oncology, Vol. 9, No. 3, 09.1996, p. 541-545.

Research output: Contribution to journalArticle

Colleoni, M, Biasin, M, Boni, L, Nelli, P, Pancheri, F, Vicario, G, Sgarbossa, G, Mastrapasqua, G, Infantolino, D & Manente, P 1996, 'Prognostic value of proliferating cell nuclear antigen (PCNA) expression in unresectable hepatocellular carcinoma', International Journal of Oncology, vol. 9, no. 3, pp. 541-545.
Colleoni, Marco ; Biasin, Mariarosa ; Boni, Luca ; Nelli, Patrizia ; Pancheri, Francesca ; Vicario, Giovanni ; Sgarbossa, Gigliola ; Mastrapasqua, Giorgio ; Infantolino, Domenico ; Manente, Paolo. / Prognostic value of proliferating cell nuclear antigen (PCNA) expression in unresectable hepatocellular carcinoma. In: International Journal of Oncology. 1996 ; Vol. 9, No. 3. pp. 541-545.
@article{29d8d9fd07d542df888c48bad995117d,
title = "Prognostic value of proliferating cell nuclear antigen (PCNA) expression in unresectable hepatocellular carcinoma",
abstract = "Recent studies indicate that evaluation of cell proliferation in malignant tumors may have prognostic value, but limited data are available on its expression in hepatocellular carcinoma. We therefore evaluated the prognostic tool of PCNA antigen expression on paraffin-embedded sections of 54 patients with hepatocellular carcinoma and concomitant cirrhosis. According to the number of positive cells, the PCNA expression ranged between 0.8 and 47{\%}, and was divided into two groups (Group A, PCNA ≤5.5{\%}; Group B, PCNA >5.5{\%}). The two groups of patients were numerically well balanced. Median survival was 16 months for group A and 12 months for group B. According to the Cox multivariate analysis, PCNA expression (P=0.002), TNM stage (P-0.009) and ECOG performance status (P",
keywords = "hepatocellular carcinoma, PCNA expression, prognostic factors",
author = "Marco Colleoni and Mariarosa Biasin and Luca Boni and Patrizia Nelli and Francesca Pancheri and Giovanni Vicario and Gigliola Sgarbossa and Giorgio Mastrapasqua and Domenico Infantolino and Paolo Manente",
year = "1996",
month = "9",
language = "English",
volume = "9",
pages = "541--545",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "3",

}

TY - JOUR

T1 - Prognostic value of proliferating cell nuclear antigen (PCNA) expression in unresectable hepatocellular carcinoma

AU - Colleoni, Marco

AU - Biasin, Mariarosa

AU - Boni, Luca

AU - Nelli, Patrizia

AU - Pancheri, Francesca

AU - Vicario, Giovanni

AU - Sgarbossa, Gigliola

AU - Mastrapasqua, Giorgio

AU - Infantolino, Domenico

AU - Manente, Paolo

PY - 1996/9

Y1 - 1996/9

N2 - Recent studies indicate that evaluation of cell proliferation in malignant tumors may have prognostic value, but limited data are available on its expression in hepatocellular carcinoma. We therefore evaluated the prognostic tool of PCNA antigen expression on paraffin-embedded sections of 54 patients with hepatocellular carcinoma and concomitant cirrhosis. According to the number of positive cells, the PCNA expression ranged between 0.8 and 47%, and was divided into two groups (Group A, PCNA ≤5.5%; Group B, PCNA >5.5%). The two groups of patients were numerically well balanced. Median survival was 16 months for group A and 12 months for group B. According to the Cox multivariate analysis, PCNA expression (P=0.002), TNM stage (P-0.009) and ECOG performance status (P

AB - Recent studies indicate that evaluation of cell proliferation in malignant tumors may have prognostic value, but limited data are available on its expression in hepatocellular carcinoma. We therefore evaluated the prognostic tool of PCNA antigen expression on paraffin-embedded sections of 54 patients with hepatocellular carcinoma and concomitant cirrhosis. According to the number of positive cells, the PCNA expression ranged between 0.8 and 47%, and was divided into two groups (Group A, PCNA ≤5.5%; Group B, PCNA >5.5%). The two groups of patients were numerically well balanced. Median survival was 16 months for group A and 12 months for group B. According to the Cox multivariate analysis, PCNA expression (P=0.002), TNM stage (P-0.009) and ECOG performance status (P

KW - hepatocellular carcinoma

KW - PCNA expression

KW - prognostic factors

UR - http://www.scopus.com/inward/record.url?scp=0029832919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029832919&partnerID=8YFLogxK

M3 - Article

C2 - 21541548

AN - SCOPUS:0029832919

VL - 9

SP - 541

EP - 545

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 3

ER -